Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

被引:49
作者
Cprek, Jessica B. [1 ,2 ]
Gallagher, Jason C. [1 ]
机构
[1] Temple Univ, Dept Pharm Practice, Philadelphia, PA 19122 USA
[2] Virtua Hlth Syst, Voorhees, NJ USA
关键词
D O I
10.1128/AAC.01569-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We describe outcomes of patients with infections with carbapenem-resistant Klebsiella pneumoniae (CRKP) who received ertapenem-containing double-carbapenem therapy (ECDCT). Clinical success was observed in 7/18 (39%) patients overall: bloodstream infections, 3/7 (43%); pneumonia, 1/5 (20%); intraabdominal infections, 0/2 (0%); urinary tract infections, 2/3 (67%); and a skin and skin structure infection, 1/1 (100%). Microbiologic success was observed in 11/14 (79%) evaluable patients; 5/18 (28%) patients died. ECDCT may be effective for CRKP infections with limited treatment options.
引用
收藏
页码:669 / 673
页数:5
相关论文
共 18 条
[1]   Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobactetiaceae [J].
Anderson, K. F. ;
Lonsway, D. R. ;
Rasheed, J. K. ;
Biddle, J. ;
Jensen, B. ;
McDougal, L. K. ;
Carey, R. B. ;
Thompson, A. ;
Stocker, S. ;
Limbago, B. ;
Patel, J. B. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (08) :2723-2725
[2]   Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae [J].
Bulik, Catharine C. ;
Nicolau, David P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) :3002-3004
[3]   Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae [J].
Ceccarelli, Giancarlo ;
Falcone, Marco ;
Giordano, Alessandra ;
Mezzatesta, Maria Lina ;
Caio, Carla ;
Stefani, Stefania ;
Venditti, Mario .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) :2900-2901
[4]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[5]  
Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI
[6]   Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae [J].
Giamarellou, Helen ;
Galani, Lambrini ;
Baziaka, Fotini ;
Karaiskos, Ilias .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) :2388-2390
[7]   CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting [J].
Horan, Teresa C. ;
Andrus, Mary ;
Dudeck, Margaret A. .
AMERICAN JOURNAL OF INFECTION CONTROL, 2008, 36 (05) :309-332
[8]   Carbapenem Resistance Among Klebsiella pneumoniae Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns [J].
Hussein, Khetam ;
Sprecher, Hanna ;
Mashiach, Tania ;
Oren, Ilana ;
Kassis, Imad ;
Finkelstein, Renato .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (07) :666-671
[9]  
Karaiskos I, 2013, 53 INT C ANT AG CHEM
[10]   Aminoglycosides: Nephrotoxicity [J].
Mingeot-Leclercq, MP ;
Tulkens, PM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1003-1012